CME Information: Obesity
Effective Management of Obesity Begins in Primary Care
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
- Summarize guidelines and best practices for the treatment of obesity
- Demonstrate the ability to discuss obesity with primary care patients, assessing their readiness for change and which options are most likely to succeed
- Identify evidence-based and FDA-approved pharmacotherapeutic treatment options for obesity
- Recognize indications, and methods for individualized medication selection and usage, for obesity pharmacotherapies in a primary care setting
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Novo Nordisk Inc.
Tuition
Complimentary
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statements
Physician Continuing Education
Live Internet Activity
Primary Care Network designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Online On-Demand Enduring Material
Primary Care Network designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other healthcare professionals will be issued a certificate of participation.
Primary Care Network has been awarded Accreditation with Commendation (2013-2019) by the Accreditation Council for Continuing Medical Education (ACCME).
Date of Release/Expiration
Live Activity
Wednesday March 6, 2019 from 3:00pm – 4:00pm EST.
Enduring Material
The enduring material will be available from March 6, 2019 – September 6, 2019.
Target Audience
The primary audience will encompass the full spectrum of professionals who play a role in providing health care for people with obesity, including physicians (primary care, internal medicine, and those of relevant specialties such as endocrinology or cardiology), nurse practitioners, mental health providers, dietitians/nutritionists, and exercise professionals.
Estimated Time to Complete
This activity consists of one session which should take approximately 1 hour to complete.
Method of Participation
There are no fees to participate in this activity. To participate in the activity, go to www.ObesitySeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the pre and post-test and activity evaluation. Participants must receive a minimum score of 70% on the post-test in order to receive a certificate.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Statement of Disclosure and Independence
It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are planned, developed, and conducted in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Essential Areas and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are considered Planning Committee Members. Planning Committee Members include individuals involved in a CME activity who may develop, edit, review and/or present content. Planning Committee Members are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.
The faculty reported the following relevant financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Presenters
Caroline M. Apovian, MD
Consulting Fee: Merck, Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, EnteroMedics, Scientific Intake, SetPoint Health, Rhythm, Xeno Biosciences, Gelesis, Ferring, Takeda, Novo Nordisk
Research Funding: Aspire Bariatrics, GI Dynamics, Pfizer, Gelesis, Orexigen, MetaProteomics, Takeda, The Dr. Robert C. and Veronica Atkins Foundation and MYOS Corporation
Samar Hafida, MD
Has no relevant financial relationships to disclose
The planners and managers reported the following relevant financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Brian Koffman, MDCM, DCFP, DABFM, MS Ed
Primary Care Netword CME Content Reviewer
Reported Relevant Financial Relationship: Advisory Board & Speaker’s Bureau: Ironwood Pharmaceuticals
Patient Speaker: Juno Therapeutics, Verastem
The following PCN planner and manager, Jill Hays, hereby state that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unapproved/Off Label Use (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.
Contact Information
Accreditation Support:
Please contact Primary Care Network at http://www.primarycarenetwork.org/.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact ObesitySeriesLive at 877-394-1306 or at Support@ObesitySeriesLive.com
CME Information: ObesityWeek 2017 Highlights
Online Symposia Highlights from TOS’s 2017 Annual Meeting at ObesityWeek:
Examining Successful Obesity Practice Models in a Variety of Delivery Settings
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
- Incorporate knowledge about coding for reimbursement into the clinical practice of health care providers to support their ability to treat the underlying disease of overweight and obesity
- Incorporate knowledge about best practices to develop and run effective clinics that treat overweight and obesity
Acknowledgement
This activity is supported by an educational grant from Novo Nordisk.
Tuition
Complimentary
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PlatformQ Health Education, LLC. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statements
Enduring Material
Boston University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Program Overview
Most recent national estimates suggest that 36% of adults and 17% of youth in the United States are considered obese. Further, comorbidities secondary to obesity contribute to a significant decrease in patients’ quality of life and increase in economic burden. With multiple possible etiologies, clinicians are continuously challenged to provide effective approaches in obesity and overweight management. Primary care physicians play an important role in the management of chronic illnesses especially obesity. However, they feel unequipped and inadequately supported to address the complexity of an efficient and coordinated management of overweight and obesity clinics. Furthermore, they ascribe the inability to lose weight to a lack of patient motivation and adherence to weight management therapies, particularly those involving lifestyle changes in diet and exercise. The Centers for Medicaid and Medicare Services (CMS) reimburses for obesity intensive behavioral therapy rendered in the primary care setting, but challenges in reimbursement remain beyond the 6-month contingency of 3-kg weight loss. Furthermore, several societies and organizations, including, TOS, the American Heart Association and the American College of Cardiology, recommend that physicians screen for overweight and obesity in their practice and provide intensive behavioral counseling. Despite the reimbursement incentive and recommendation, the rates of screening and counseling remain low in these settings. Multidisciplinary clinic models, documentation/coding approaches, and electronic health record protocol implementations are all potential solutions and should be made available and accessible to clinicians. Clinicians would benefit from education by experts from obesity clinics in various settings with discussions focused on effective practice models for overweight and obesity clinics, recommendations on appropriate coding for reimbursement with suitable documentation, and insights on implementing an electronic health record that supports an obesity management protocol. Education on practical approaches to run an effective obesity medicine clinic/practice will enable primary care and community clinicians to be more inclined to impact the lives of their patients and slow the epidemic.
Intended Audience
The intended audience for this activity consists of health care providers of people who may be obese and need pharmacotherapeutic interventions and includes the following groups:
The target audience consists of physicians (general medicine, internal medicine, family practice), endocrinologists, surgeons, pediatricians, dietitians, psychologists, physician assistants, nurses, nurse practitioners, rehabilitation/exercise therapists, physical/occupational therapists, clinicians, nutritionists, trainees, basic and clinical research scientists, and social workers
- Providers: Physicians (primary care and those of relevant specialties such as endocrinology or cardiology), nurse practitioners, physician assistants
- Lifestyle specialists: Mental health providers, dietitians/nutritionists, exercise professionals
Date of Release/Expiration
Enduring Material
The enduring material will be available from November 30, 2017 – May 30, 2018.
Estimated Time to Complete
This activity consists of 3 30-minute modules, which should take approximately 1.5 hours to complete.
Faculty
Nadia B. Pietrzykowska, MD, FACP
President and Medical Director
Weight & Life MD
Ewing, New Jersey
Deborah Bade Horn, DO, MPH, MFOMA
Medical Director, Clinical Assistant Professor
University of Texas McGovern Medical School
Houston, Texas
Sean Hashmi, MD, MS, FASN
Assistant Area Medical Director
Kaiser Permanente
Woodland Hills, California
CME Course Advisor
Caroline Apovian, MD
Professor of Medicine and Pediatrics, Section of Endocrinology, Diabetes, and Nutrition
Boston University School of Medicine
Director, Nutrition and Weight Management Center
Boston Medical Center
Boston, Massachusetts
Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Financial Disclosures
Presenters
Nadia B. Pietrzykowska, MD, FACP, has no relevant financial relationships to disclose.
Deborah Bade Horn, DO, MPH, MFOMA, Advisory Boards and Speakers Bureau relationship with Novo, Nordisk (pharmaceuticals); Advisory Boards and Speakers Bureau relationship with Orexigen (pharmaceuticals); Advisory Board relationship with Optifast (pharmaceuticals)
Sean Hashmi, MD, MS, FASN, has no relevant financial relationships to disclose.
Boston University School of Medicine CME course Advisor
Caroline Apovian, MD, Nutrisystem: Corporate Advisory Board (Self) Food; Zafgen: Corporate Advisory Board (Self) Pharmaceuticals;
Sanofi-Aventis: Corporate Advisory Board (Self) Pharmaceuticals; Orexigen: Corporate Advisory Board (Self) Pharmaceuticals; NovoNordisk: Corporate Advisory Board (Self) Pharmaceuticals; GI Dynamics: Corporate Advisory Board (Self) Medical Device; GI Dynamics: Contracted Research (Self) Medical Device; Scientific Intake: Corporate Advisory Board (Self) Medical Device; Gelesis: Corporate Advisory Board (Self) Medical Device; Gelesis: Contracted Research (Self) Medical Device; Science-Smart LLC: Stock Options (including future) (Self) Food/Supplement; Energesis: Contracted Research (Self) Biotech
Boston University School of Medicine
Naomi Moeller, Senior Program Manager, has no relevant financial relationships to disclose.
The Obesity Society CME Oversight Reviewer
Van S. Hubbard, MD, PhD, has no relevant financial relationships to disclose
The Obesity Society Annual Program Committee – Planners
Jaime Almandoz, MD, has no relevant financial relationships to disclose
Lori M. Zeltser, PhD, has no relevant financial relationships to disclose
Sharon J. Herring, MD, has no relevant financial relationships to disclose
PlatformQ Health Education, LLC
Karen Greb-Murphy, Senior Program Manager, has no relevant financial relationships to disclose.
Method of Participation
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1.5 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
DISCLAIMERS (if applicable):
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Boston University School of Medicine, ObesitySeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Contact Information
Please send content inquiries to: cme@joslin.harvard.edu
Please send CME inquiries to: cme@bu.edu
For issues with your CME Certificate, please contact ObesitySeriesLive at 877-394-1306 or at Support@ObesitySeriesLive.com.
CME Infromation: Pharmacotherapy of Obesity
Pharmacotherapy of Obesity: Practical Applications for Clinical Care
Presented by Boston University School of Medicine in collaboration with PlatformQ Health Education, LLC and The Obesity Society ACKNOWLEDGEMENT TUITION ACCREDITATION STATEMENT CREDIT DESIGNATION STATEMENTS PROGRAM OVERVIEW TARGET AUDIENCE
LEARNING OBJECTIVES
DATE OF RELEASE/EXPIRATION Enduring Material ESTIMATED TIME TO COMPLETE FACULTY Scott Kahan, MD, MPH Kimberly A. Gudzune, MD, MPH CME Course Advisor: DISCLOSURE POLICY FINANCIAL DISCLOSURES
METHOD OF PARTICIPATION HARDWARE/SOFTWARE REQUIREMENTS DISCLAIMERS (if applicable): ALL PROGRAMS, ACTIVITIES, AND MATERIALS PROVIDED BY BOSTON UNIVERSITY OFFICE OF CONTINUING MEDICAL EDUCATION OR ITS ASSOCIATES ARE PROVIDED ON THE CONDITION THAT THEY BE USED SOLELY FOR EDUCATIONAL PURPOSES BY QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE CONTINUING MEDICAL EDUCATION PROGRAMS, ACTIVITIES OR MATERIALS. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material. The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Boston University School of Medicine, ObesitySeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. CONTACT INFORMATION: For issues with your CME Certificate, Please contact ObesitySeriesLive at 977–394–1306 or at Support@ObesitySeriesLive.com |
CME Information: Obesity Management Perspectives
Expert Obesity Management Perspectives and Updates from ObesityWeekSMJointly provided by Boston University School of Medicine and PlatformQ Health Education, LLC
ACKNOWLEDGEMENT TUITION ACCREDITATION STATEMENT CREDIT DESIGNATION STATEMENTS DATE OF RELEASE/EXPIRATION LEARNING OBJECTIVES
TARGET AUDIENCE ESTIMATED TIME TO COMPLETE METHOD OF PARTICIPATION HARDWARE/SOFTWARE REQUIREMENTS FACULTY DISCLOSURE The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable): This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMERS CONTACT INFORMATION Technical Support: Disclaimer: |
CME Information: Lung Cancer EGFR
Updates in Lung Cancer:
|
 |
ACKNOWLEDGEMENT
This educational activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
TUITION
Complimentary
ACCREDITATION STATEMENT
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Internet Activity
Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2.0 hour of Category 1 credit for completing this program
DATE OF RELEASE/EXPIRATION
Live Activity
Wednesday, September 7, 2016 from 10:00AM EST – 11:00AM EST
Enduring Material
The enduring material will be available from Wednesday, September 7, 2016 to Tuesday, March 7, 2016.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
| • | Review the pathophysiology of NSCLC and the role played by EGFR and activating EGFR mutations |
| • | Provide the rationale for EGFR mutation testing to identify appropriate patients for targeted therapy |
| • | Evaluate currently approved EGFR inhibitors and their role in the treatment of NSCLC |
| • | Discuss the adverse events common to this drug class and how individual drugs might differ, and present management strategies |
INTENDED AUDIENCE
Oncologists, oncology nurses, nurse practitioners, physician assistants, internists, primary care physicians, pulmonologists, and other health care professionals who treat patients with lung cancer.
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
| Presenters | Disclosures |
| Geoffrey R. Oxnard, MD |
Has nothing to disclose. |
|
|
|
|
|
| Providers | Disclosures |
| Einstein-Montefiore Center for Continuing Medical Education | The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity. |
|
|
|
| Peer Reviewer | Disclsoures |
| Rasim A. Gucalp, MD | To be posted prior to the live internet activity |
| PlatformQ Health Education, LLC | Disclsoures |
| Hamsa Jaganathan, Medical Director | Has nothing to disclose relevant to this activity |
| Randi O’Hara, Senior Program Manager | Has nothing to disclose relevant to this activity. |
DISCLAIMERS (if applicable):
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
CONTACT INFORMATION
Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.
Technical Support:
For issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com
CME Information: Lung Cancer ALK
Updates in Lung Cancer:
|
|
ACKNOWLEDGEMENT
This educational activity is supported by an educational grant from Ariad Pharmaceuticals, Inc.
TUITION
Complimentary
ACCREDITATION STATEMENT
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Internet Activity
Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2.0 hour of Category 1 credit for completing this program
DATE OF RELEASE/EXPIRATION
Live Activity
Wednesday, September 7, 2016 from 11:00AM EST – 12:00PM EST
Enduring Material
The enduring material will be available from Wednesday, September 7, 2016 to Tuesday, March 7, 2016
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
| • | Provide rationale for testing for ALK mutations and use of ALK inhibitors |
| • | Evaluate latest clinical data on new and emerging ALK inhibitors and combinations for use in patients with NSCLC |
| • | Manage resistance to ALK inhibitors with appropriate second-line options |
TARGET AUDIENCE
Medical oncologists, radiation oncologists, GI surgeons, GI internists, fellows and other health care professionals (primary care physicians, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with gastric cancer.
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
| Presenters | Disclosures |
| Geoffrey R. Oxnard, MD |
Has nothing to disclose. |
| Providers | Disclosures |
| Einstein-Montefiore Center for Continuing Medical Education | The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity. |
| Peer Reviewer | Disclsoures |
| Rasim A. Gucalp, MD | To be posted prior to the live internet activity |
| PlatformQ Health Education, LLC | Disclsoures |
| Hamsa Jaganathan, Medical Director | Has nothing to disclose relevant to this activity |
| Randi O’Hara, Senior Program Manager | Has nothing to disclose relevant to this activity. |
DISCLAIMERS (if applicable):
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
CONTACT INFORMATION
Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.
Technical Support:
For issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com
CME Information: Gastric Cancer
Individualizing Care For Patients with Advanced/Metastatic Gastric Cancer
|
ACKNOWLEDGEMENT
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
TUITION
Complimentary
ACCREDITATION STATEMENT
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Internet Activity
Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program
DATE OF RELEASE/EXPIRATION
Live Activity
Wednesday, August 31, 2016 from 2:00 PM EST – 3:00 PM EST
Enduring Material
The enduring material will be available from August 31, 2016 to February 28, 2017.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
| • | Identify and select effective chemotherapy agents for treatment-naive patients with metastatic gastric cancer |
| • | Evaluate the safety and efficacy of available and emerging targeted therapies in the first-line setting for advanced/metastatic gastric cancer |
| • | Examine new and promising data from available and emerging treatment options in the second-line setting |
TARGET AUDIENCE
Medical oncologists, radiation oncologists, GI surgeons, GI internists, fellows and other health care professionals (primary care physicians, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with gastric cancer.
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
| Presenters | Disclosures |
| David I. Ilson, MD |
Consulting Fee: Novartis; Roche; Genentech; Lilly |
| Manish A. Shah, MD |
Consulting Fee: Lilly |
|
|
| Peer Reviewer | Disclsoures |
| Amit K. Verma, MD | Has no disclosures to report relevant to this activity. |
|
|
|
| Providers | Disclosures |
| Einstein-Montefiore Center for Continuing Medical Education | The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity. |
|
|
|
| PlatformQ Health Education, LLC | Disclsoures |
| Hamsa Jaganathan, Medical Director | Has nothing to disclose relevant to this activity |
| Karen Greb-Murphy, Program Manager | Has nothing to disclose relevant to this activity. |
DISCLAIMERS (if applicable):
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
CONTACT INFORMATION
Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.
Technical Support:
For issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com
CME Information: Pediatric Neuroblastoma
Pediatric Patients with High-Risk Neuroblastoma:
Perspectives on Diagnosis and Management
  |
ACKNOWLEDGEMENT
This activity is supported by United Therapeutics.
TUITION
Complimentary
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Internet Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DATE OF RELEASE/EXPIRATION
Live Activity
Thursday, June 9, 2016 from 12:00PM ET – 1:00PM ET.
Tuesday, September 20, 2016 from 12:00PM ET – 1:00PM ET.
Enduring Material
The enduring material will be available from June 9, 2016 to September 20, 2017.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
| • | Review treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments |
| • | Manage immediate and late effects of therapy for pediatric neuroblastoma |
| • | Describe patient-related needs associated with agents used for high-risk pediatric neuroblastoma |
| • | Evaluate current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma |
| • | Provide collaborative comprehensive care for patients with high-risk pediatric neuroblastoma |
| • | Counsel patients and caregivers to look for potential treatment outcomes in order to effectively address immediate and late effects of treatment |
TARGET AUDIENCE
This activity is intended for oncologists, surgeons, nurses, pharmacists, physician assistants, and health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma.
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship: |
| Navin Pinto, MD |
None |
| Jennifer Saggio, MSN, CRNP, CPON |
Speaker’s Bureau: United Therapeutics |
| Jason Shohet, MD, PhD |
None |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner | Reported Financial Relationship: |
| Hamsa Jaganathan Medical Director PlatformQ Health Education, LLC | Has nothing to disclose. |
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following PlatformQ Health Education, LLC planner, Shaina Druy, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMERS (if applicable):
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
CONTACT INFORMATION
Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com
CME Information: HER2 Positive Breast Cancer
Updates on HER2 Positive
Breast Cancer Management
|
ACKNOWLEDGEMENT
This educational activity is supported by an educational grant from Genentech.
TUITION
Complimentary
ACCREDITATION STATEMENT
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Internet Activity
Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2.0 hour of Category 1 credit for completing this program
DATE OF RELEASE/EXPIRATION
Live Activity
Friday, June 10, 2016 from 1:00PM EST- 2:00PM EST
Enduring Material
The enduring material will be available from June 10, 2016 to June 10, 2017.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
| • | Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings |
| • | Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment |
TARGET AUDIENCE
Oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
| Presenters | Disclosures |
| Harold Burstein, MD, PhD |
To be posted prior to the live internet activity |
| Eric Winer, MD |
To be posted prior to the live internet activity |
| Providers | Disclosures |
| Einstein-Montefiore Center for Continuing Medical Education | The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity. |
| Peer Reviewer | Disclosures |
| Jesus Anampa Mesias, MD | To be posted prior to the live internet activity |
| PlatformQ Health Education, LLC | Disclosures |
| Hamsa Jaganathan, Medical Director | To be posted prior to the live internet activity |
| Randi O’Hara, Senior Program Manager | Has nothing to disclose relevant to this activity. |
DISCLAIMERS (if applicable):
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
CONTACT INFORMATION
Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com
CME Information: Breast Cancer ASCO
Advances in Breast Cancer Management:
Updates from ASCO 2016
| |
ACKNOWLEDGEMENT
This activity is supported by Puma Biotechnology.
TUITION Complimentary
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
Live Internet Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DATE OF RELEASE/EXPIRATION
Live Activity
Friday, June 10, 2016 from 12:00PM ET – 1:00PM ET.
Enduring Material
The enduring material will be available from June 10, 2016 – December 10, 2016.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
| • | Describe the efficacy and safety of new and emerging treatment approaches for HER2-positive breast cancer in the neoadjuvant, adjuvant, and metastatic settings |
| • | Summarize the efficacy and safety of new and emerging targeted treatment approaches for patients with advanced breast cancer who have developed endocrine resistance |
| • | Evaluate how biomarkers are being used to select treatment regimens that may be particularly effective in patients with TNBC |
| • | Select appropriate combinations of chemotherapy and endocrine therapy in the neoadjuvant and adjuvant setting for patients with breast cancer |
TARGET AUDIENCE
This activity is intended for medical oncologists, surgical oncologists, pathologists, general surgeons, medical fellows, pharmacists, oncology nurse practitioners/physician assistants, and other clinicians involved in the diagnosis and treatment of breast cancer.
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FACULTY DISCLOSURE
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship: |
| Harold J. Burstein, MD, PhD |
None |
| Name of Planner | Reported Financial Relationship: |
| Anne Roc PhD, Medical Director | Has nothing to disclose. |
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. The following PlatformQ Health Education, LLC planner, Shaina Druy, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMERS (if applicable):
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
CONTACT INFORMATION
Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com